Enfermedad por virus ebola: actualización

Feldmann, 2011, Ebola haemorrhagic fever, Lancet, 377, 849, 10.1016/S0140-6736(10)60667-8 Marí Saez, 2015, Investigating the zoonotic origin of the West African Ebola epidemic, EMBO Mol Med, 7, 17, 10.15252/emmm.201404792 Baize, 2014, Emergence of Zaire Ebola virus disease in Guinea, N Engl J Med, 371, 1418, 10.1056/NEJMoa1404505 Kuhn, 2014, Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014, Viruses, 6, 4760, 10.3390/v6114760 Park, 2015, Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone, Cell, 161, 1516, 10.1016/j.cell.2015.06.007 World Health Organization (WHO) Ebola Situation Reports [consultado 21 Sep 2015]. Disponible en: http://www.who.int/csr/disease/ebola/situation-reports/en/ Mora-Rillo, 2015, Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid, Spain, Lancet Respir Med, 3, 554, 10.1016/S2213-2600(15)00180-0 Chevalier, 2014, Ebola virus disease cluster in the United States — Dallas County, Texas, 2014, MMWR Morb Mortal Wkly Rep, 63, 1087 Bah, 2015, Clinical presentation of patients with Ebola virus disease in Conakry, Guinea, N Engl J Med, 372, 40, 10.1056/NEJMoa1411249 2014, Ebola virus disease in West Africa — the first 9 months of the epidemic and forward projections, N Engl J Med, 371, 1481, 10.1056/NEJMoa1411100 Schieffelin, 2014, Clinical illness and outcomes in patients with Ebola in Sierra Leone, N Engl J Med, 371, 2092, 10.1056/NEJMoa1411680 Chan, 2014, Ebola virus disease in West Africa — No early end to the outbreak, N Engl J Med, 371, 1183, 10.1056/NEJMp1409859 Osterholm, 2015, Transmission of Ebola viruses: What we know and what we do not know, mBio, 6, e00137 Christie, 2015, Possible sexual transmission of Ebola virus — Liberia, 2015, MMWR Morb Mortal Wkly Rep, 64, 479 World Health Organization (WHO). Interim advice on the sexual transmission of the Ebola virus disease [consultado 21 Sep 2015]. Disponible en http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/ Bausch, 2007, Assessment of the risk of Ebola virus transmission from bodily fluids and fomites, J Infect Dis, 196, S142, 10.1086/520545 Lopaz, 2015, First secondary case of Ebola outside Africa: Epidemiological characteristics and contact monitoring, Spain, September to November 2014, Euro Surveill, 20, pii=21003, 10.2807/1560-7917.ES2015.20.1.21003 Sullivan, 2003, Ebola virus pathogenesis: Implications for vaccines and therapies, J Virol, 77, 9733, 10.1128/JVI.77.18.9733-9737.2003 Moller-Tank, 2015, Ebola virus entry: A curious and complex series of events, PLoS Pathog, 11, e1004731, 10.1371/journal.ppat.1004731 Carette, 2011, Ebola virus entry requires the cholesterol transporter Niemann-Pick C1, Nature, 477, 340, 10.1038/nature10348 Mohamadzadeh, 2007, How Ebola and Marburg viruses battle the immune system, Nat Rev Immunol, 7, 556, 10.1038/nri2098 Rasmussen, 2014, Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance, Science, 346, 987, 10.1126/science.1259595 Haas CN. On the quarantine period for ebola virus. PLoS Currents. 2014;6. ecurrents.outbreaks.2ab4b76ba7263ff0f084766e43abbd89. doi:10.1371/currents.outbreaks.2ab4b76ba7263ff0f084766e43abbd89. Ansumana, 2015, Ebola in Freetown area, Sierra Leone—a case study of 581 patients, N Engl J Med, 372, 587, 10.1056/NEJMc1413685 Lado M, Walker NF, Baker P, Haroon S, Brown CS, Youkee D, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. The Lancet Infectious Diseases Published Online First: 2015. 10.1016/S1473-3099(15)00137-1. Hunt, 2015, Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study, Lancet Infect Dis, 15, 1292, 10.1016/S1473-3099(15)00144-9 Chertow, 2014, Ebola virus disease in West Africa—clinical manifestations and management, N Engl J Med, 371, 2054, 10.1056/NEJMp1413084 Zachariah, 2015, The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: Reason to worry?, Lancet Infect Dis, 15, 989, 10.1016/S1473-3099(15)00160-7 Lyon, 2014, Clinical care of two patients with Ebola virus disease in the United States, N Engl J Med, 371, 2402, 10.1056/NEJMoa1409838 Wolf, 2015, Severe Ebola virus disease with vascular leakage and multiorgan failure: Treatment of a patient in intensive care, Lancet, 385, 1428, 10.1016/S0140-6736(14)62384-9 Kraft, 2015, The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States, Clin Infect Dis, 61, 496, 10.1093/cid/civ334 Kreuels, 2014, A case of severe Ebola virus infection complicated by gram-negative septicemia, N Engl J Med, 371, 2394, 10.1056/NEJMoa1411677 Schibler, 2015, Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: A case report, Lancet Infect Dis, 15, 1034, 10.1016/S1473-3099(15)00229-7 Liddell, 2015, Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States, Ann Intern Med, 163, 81, 10.7326/M15-0530 Florescu, 2015, Administration of brincidofovir and convalescent plasma in a patient with Ebola virus disease, Clin Infect Dis, 61, 969, 10.1093/cid/civ395 Sissoko, 2015, Favipiravir in patients with Ebola virus disease: Early results of the JIKI trial in Guinea Clark, 2015, Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study, Lancet Infect Dis, 15, 905, 10.1016/S1473-3099(15)70152-0 Kibadi, 1999, Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo, J Infect Dis, 179, S13, 10.1086/514288 Qureshi, 2015, Study of Ebola virus disease survivors in Guinea, Clin Infect Dis, 61, 1035, 10.1093/cid/civ453 Varkey, 2015, Persistence of Ebola virus in ocular fluid during convalescence, N Engl J Med, 372, 2423, 10.1056/NEJMoa1500306 Reusken, 2015, Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014, J Clin Virol, 62, 124, 10.1016/j.jcv.2014.11.007 Akerlund, 2015, Shedding of Ebola virus in an asymptomatic pregnant woman, N Engl J Med, 372, 2467, 10.1056/NEJMc1503275 Broadhurst, 2015, ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: A field validation study, Lancet, 386, 867, 10.1016/S0140-6736(15)61042-X World Health Organization (WHO). Compassionate use of experimental treatments for Ebola virus disease: outcomes in 14 patients admitted from August to November, 2014 [consultado 21 Sep 2015]. Dispponible en http://www.who.int/medicines/ebola-treatment/outcomes_experimental_therapies/en/ World Health Organization (WHO). Manual for the care and management of patients in Ebola care units. 2015 [consultado 21 Sep 2015]. Disponible en: http://www.who.int/csr/resources/publications/ebola/patient-care-CCUs/en/ Chertow, 2015, Loperamide therapy for voluminous diarrhea in Ebola virus disease, J Infect Dis, 211, 1036, 10.1093/infdis/jiv001 Torabi-Parizi, 2015, Ethical and practical considerations in providing critical care to patients with Ebola virus disease, Chest, 147, 1460, 10.1378/chest.15-0278 Furuta, 2009, T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections, Antiviral Res, 82, 95, 10.1016/j.antiviral.2009.02.198 Oestereich, 2014, Antiviral research, Antiviral Res, 105, 17, 10.1016/j.antiviral.2014.02.014 Mupapa, 1999, Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee, J Infect Dis, 179, S18, 10.1086/514298 Sadek, 1999, Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: Determinants of survival, J Infect Dis, 179, S24, 10.1086/514311 World Health Organization (WHO). Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease [consultado 21 Sep 2015]. Disponible en: http://www.who.int/csr/resources/publications/ebola/convalescent-treatment/en/ Qiu, 2014, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp, Nature, 514, 47, 10.1038/nature13777 Sprecher, 2015, Personal protective equipment for filovirus epidemics: A call for better evidence, J Infect Dis, 212, S98, 10.1093/infdis/jiv153 Jacobs, 2015, Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: A case-series of health-care workers, Lancet Infect Dis, 15, 1300, 10.1016/S1473-3099(15)00228-5 Lai, 2015, Emergency postexposure vaccination with vesicular stomatitis virus–vectored Ebola vaccine after needlestick, JAMA, 313, 1249, 10.1001/jama.2015.1995 Henao-Restrepo, 2015, Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: Interim results from the Guinea ring vaccination cluster-randomised trial, Lancet, 386, 857, 10.1016/S0140-6736(15)61117-5 Ledgerwood, 2014, Chimpanzee adenovirus vector Ebola vaccine — Preliminary report, N Engl J Med, 10.1056/NEJMoa1410863 Zhu, 2015, Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: Preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial, Lancet, 385, 2272, 10.1016/S0140-6736(15)60553-0 Marzi, 2015, VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain, Science, 349, 739, 10.1126/science.aab3920